Surgery platform

Article

Oertli launches its new surgery platform for anterior and vitreoretinal procedures.

At this year’s ESCRS, Oertli will be launching its new surgery platform for anterior and vitreoretinal procedures.

The OS4 will be premiered at the Oertli booth, B09, during the congress exhibition. "We have redefined the concept of the operating platform for cataract, glaucoma and retina surgery," said Thomas Bosshard, head of marketing and sales. "The OS4 includes everything we are good at: cutting-edge technology, perfect design, irresistible simplicity, the highest degree of safety and Swiss quality."

For your chance to experience this new platform, visit the Oertli booth during the ESCRS congress, 12–16 September.

Booth number: B09

Website:www.oertli-instruments.com

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.